The cash virtual companies have for drug development may be limited. In any event, a small biotech company, virtual or not, has nowhere near two billion dollars to bring a drug to market.

The pharmaceutical industry has rapidly adopted AI and GenAI to expedite drug discovery, development, and manufacturing processes. Companies like Dr Reddy's, Novartis, Sanofi, Johnson & Johnson ...

As it now costs a whopping $800 million to develop a new drug, American researchers have developed a forecasting computer model which could reduce drug development costs, saving hundreds of ...

The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth. Over the past several decades, drug-development costs have risen significantly, from $250 ...

According to a recent study, the out-of-pocket clinical costs and capitalized clinical costs per approved drug were both lower for orphan drugs compared with nonorphan drugs.

That cost has skyrocketed 145% since 2003, when a Tufts study pegged the cost at $802 million—which is equal to $1.044 billion in 2013 dollars.

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods ...

The cost of drug development has risen markedly in the past 30 years, with studies now reporting values exceeding US $800 million. As these spiralling costs threaten to make the development of new ...

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential benefits to millions of patients. However, the biotech and pharmaceutical companies that develop ...